CAHILL FINANCIAL ADVISORS INC

Position in GILD — Gilead Sciences, Inc.

CIK 1600327 EDINA, MN

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$447,243

-$70,795 QoQ

Shares Held

3,540

-4.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#1,429

of 2,266 holders

Holding Since

Sep 2021

8 quarters on record

Voting authority Sole 30% Shared 0% None 70%

Healthcare · as of Jun 30, 2026

CAHILL FINANCIAL ADVISORS INC holds $3,643,630 across 6 Drug Manufacturers - General names. GILD ranks #4 (12.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	4,966	$1,261,215
2	ABBV	AbbVie Inc.	2,753	$692,764
3	MRK	Merck & Co., Inc.	4,446	$571,311
4	GILD	Gilead Sciences, Inc. This page	3,540	$447,243
5	AMGN	Amgen Inc	956	$346,186
6	PFE	Pfizer Inc	13,493	$324,911

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$447,243	3,540	-4.8%	Shares	Sole	2026-08-11
2026-03-31	$518,038	3,717	+1.0%	Shares	Sole	2026-05-13
2025-12-31	$451,560	3,679	-0.6%	Shares	Sole	2026-02-18
2025-09-30	$410,811	3,701	+2.0%	Shares	Sole	2025-11-03
2025-06-30	$402,236	3,628	+0.1%	Shares	Sole	2025-08-07
2025-03-31	$406,181	3,625	+0.1%	Shares	Sole	2025-05-15
2024-12-31	$334,564	3,622	+321.2%	Shares	Sole	2025-02-14
2021-09-30	$60,071	860	—	Shares	Sole	2021-11-16
No filing history on record for this holder in this stock.